Evidence map›Paper›PMID 35138630›Full record

ArticleBrazilian journal of microbiology : [publication of the Brazilian Society for Microbiology]2022

Chemokine production induced by Corynebacterium pseudotuberculosis in a murine model.

Thiago Doria Barral, Miriam Flores Rebouças, Dan Loureiro, José Tadeu Raynal, Thiago Jesus Sousa, Lilia Ferreira Moura-Costa, Vasco Azevedo, Roberto Meyer, Ricardo Wagner Portela

Open access · greenAbstract read
In one paragraph

Article in Brazilian journal of microbiology : [publication of the Brazilian Society for Microbiology], 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Isolation and Molecular Characterization ofAnimals : an open access journal from MDPI · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Thiago Doria BarralLaboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia State, 40110-100, Brazil.ORCID http://orcid.org/0000-0002-1252-3605
Miriam Flores RebouçasLaboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia State, 40110-100, Brazil.
Dan LoureiroLaboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia State, 40110-100, Brazil.
José Tadeu RaynalLaboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia State, 40110-100, Brazil.ORCID http://orcid.org/0000-0002-2771-0235
Thiago Jesus SousaLaboratory of Molecular and Cellular Genetics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais State, 31270-901, Brazil.ORCID http://orcid.org/0000-0001-9809-8883
Lilia Ferreira Moura-CostaLaboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia State, 40110-100, Brazil.
Vasco AzevedoLaboratory of Molecular and Cellular Genetics, Institute of Biological Sciences, Federal University of Minas Gerais, Belo Horizonte, Minas Gerais State, 31270-901, Brazil.ORCID http://orcid.org/0000-0002-4775-2280
Roberto MeyerLaboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia State, 40110-100, Brazil.ORCID http://orcid.org/0000-0002-4727-4805
Ricardo Wagner PortelaLaboratory of Immunology and Molecular Biology, Institute of Health Sciences, Federal University of Bahia, Salvador, Bahia State, 40110-100, Brazil. rwportela@ufba.br.ORCID http://orcid.org/0000-0001-9095-776X
Universidade Federal da Bahia · BRUniversidade Federal de Minas Gerais · BR

Funding

conselho nacional de desenvolvimento científico e tecnológico 313350/2019-1fapesb 022/2009
6 · The paper itself

Abstract

Corynebacterium pseudotuberculosis is the etiological agent of caseous lymphadenitis. The main clinical sign of this disease is the development of granulomas, especially in small ruminants; however, the pathways that are involved in the formation and maintenance of these granulomas are unknown. Cytokines and chemokines are responsible for the migration of immune cells to specific sites and tissues; therefore, it is possible that chemokines participate in abscess formation. This study aimed to evaluate the induction of chemokine production by two C. pseudotuberculosis strains in a murine model. A highly pathogenic (VD57) and an attenuated (T1) strain of C. pseudotuberculosis, as well as somatic and secreted antigens derived from these strains, was used to stimulate murine splenocytes. Then, the concentrations of the chemokines CCL-2, CCL-3, CCL-4, and CCL-5 and the cytokines IL-1 and TNF were measured in the culture supernatants. The VD57 strain had a higher ability to stimulate the production of chemokines when compared to T1 strain, especially in the early stages of stimulation, which can have an impact on granuloma formation. The T1 lysate antigen was able to stimulate most of the chemokines studied herein when compared to the other antigenic fractions of both strains. These results indicate that C. pseudotuberculosis is a chemokine production inducer, and the bacterial strains differ in their induction pattern, a situation that can be related to the specific behavior of each strain.

Indexed as

Corynebacterium InfectionsCorynebacterium pseudotuberculosisLymphadenitisAnimalsCytokinesDisease Models, AnimalMiceCytokinesCaseous lymphadenitisChemotaxisCorynebacteriaceaeGranuloma

Identifiers

PMID35138630
PMCPMC9151972
OpenAlexW4211206170

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.